Accounts Payable and Accrued Liabilities |
8. Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of the following (in thousands): | | | | | | | | | | | | | As of | | June 30, 2025 | | December 31, 2024 | Accounts payable and other accrued operating expenses | $ | 74,054 | | | $ | 73,033 | | Accrued clinical trial expenses | 26,935 | | | 26,068 | | Accrued professional fees | 23,116 | | | 17,895 | | Accrued technical operation expenses | 14,905 | | | 18,388 | | | | | | Accrued compensation and employee related costs | 50,198 | | | 80,312 | | Accrued royalty and milestones payable | 8,162 | | | 6,324 | | Accrued interest payable | — | | | 359 | | Revenue Interest Payments payable | 4,296 | | | 4,177 | | Accrued sales allowances and related costs | 22,956 | | | 16,762 | | Accrued French rebate payable | 10,043 | | | 5,988 | | Deferred and contingent consideration | 65,700 | | | 24,700 | | | | | | | | | | Other accrued liabilities | 4,654 | | | 11,203 | | | $ | 305,019 | | | $ | 285,209 | |
|